Shareholders

Shareholders in Chordate Medical Holding AB per 2021-09-30

Shareholder Number of shares Votes and capital %
Isak Brandberg AB   13 307 568 12,1%
 HAWOC Investment AB  11 500 000 10,4%
 Sifonen AB  9 980 613 9,1%
 Tommy Hedberg  5 929 167 5,4%
 Henrik Rammer  5 384 798 4,9%
 Bevaclean  4 875 000 4,4%
 Tiven GmbH 4 759 798 4,3%
 Försäkringsaktiebolaget Avanza Pension   2 654 606 2,8%
 Simon Angeldorff  1 850 000 1,7%
Vilhelm Sundström 1 105 802 1,2%
Others 48 875 559 44,3%
Total 110 222 911 100,0%

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

Please note that the MAR rules (Market Abuse Regulation) prohibits us from providing information to individual inquirers regarding matters of the company's share, share price, economy and financials, commercial and scientific activities, and other information that potentially can alter the Market valuation of the traded share. We refer in general to the public information published by the company for such questions. Hence, emails with such questions will not be responded to individually.

IR contact